C07D 277/82
Nitrogen atoms
C07D277/82 (Nitrogen atoms) appears on 925 US grants and 827 published applications in this corpus.
Search patents in C07D- Granted patents
- 925
- Published applications
- 827
- Assignees
- 490
- Inventors
- 2,903
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 17 | 0 |
| 1978 | 12 | 0 |
| 1979 | 4 | 0 |
| 1980 | 15 | 0 |
| 1981 | 13 | 0 |
| 1982 | 7 | 0 |
| 1983 | 12 | 0 |
| 1984 | 10 | 0 |
| 1985 | 12 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 7 | 0 |
| 1989 | 8 | 0 |
| 1990 | 10 | 0 |
| 1991 | 12 | 0 |
| 1992 | 5 | 0 |
| 1993 | 17 | 0 |
| 1994 | 18 | 0 |
| 1995 | 10 | 0 |
| 1996 | 33 | 0 |
| 1997 | 28 | 0 |
| 1998 | 24 | 0 |
| 1999 | 17 | 0 |
| 2000 | 21 | 0 |
| 2001 | 20 | 3 |
| 2002 | 26 | 31 |
| 2003 | 21 | 38 |
| 2004 | 17 | 63 |
| 2005 | 22 | 51 |
| 2006 | 32 | 37 |
| 2007 | 24 | 43 |
| 2008 | 23 | 36 |
| 2009 | 21 | 39 |
| 2010 | 28 | 47 |
| 2011 | 35 | 32 |
| 2012 | 32 | 32 |
| 2013 | 26 | 21 |
| 2014 | 31 | 29 |
| 2015 | 27 | 27 |
| 2016 | 26 | 26 |
| 2017 | 17 | 33 |
| 2018 | 14 | 30 |
| 2019 | 24 | 31 |
| 2020 | 24 | 42 |
| 2021 | 25 | 26 |
| 2022 | 19 | 17 |
| 2023 | 16 | 28 |
| 2024 | 18 | 28 |
| 2025 | 14 | 17 |
| 2026 | 9 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- Benzothiazole and quinoline derivatives and their use22 Sep 2026US 12,741,948 B2Shanghai Yao Yuan Biotechnology Co., Ltd.
- Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof31 Mar 2026US 12,590,071 B2Korea Institute of Science and Technology
- Salt of benzothiazole compound, and crystal form and use thereof24 Mar 2026US 12,583,829 B2Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
- Aryl receptor modulators and methods of making and using the same17 Mar 2026US 12,577,256 B2Nogra Pharma Limited
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Biarylamide derivatives and their use as pkmyt1 inhibitors1 Oct 2026US 2026/0297042 A1Cancer Research Technology Limited
- Fabk inhibitor compositions10 Sep 2026US 2026/0265242 A1The Texas A&M University System
- New antibiotic compounds3 Sep 2026US 2026/0258006 A1Centre National De La Recherche Scientifique
- Compounds, compositions and methods of use to treat hypoparathyroidism and osteoporosis3 Sep 2026US 2026/0258007 A1Septerna, Inc.
Most cited
By later US patents
- Novel compounds146US 5,002,953 ABeecham Group Limited · 1991
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants128US 6,720,344 B2Board of Regents, The University of Texas System · 2004
- Compounds enhancing antitumor activity of other cytotoxic agents116US 6,130,217 APfizer Inc. · 2000
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994